CorMedix Inc.
DE ˙ DB ˙ US21900C3088
7,15 € ↑0,26 (3,77%)
2026-06-05
DEL PRIS
SecurityDE:19KA / CorMedix Inc.
InstitutionJpmorgan Chase & Co
Latest Disclosed Ownership115,960 shares
Latest Disclosed Value $ 761,858
Jpmorgan Chase & Co reports 7.60% increase in ownership of 19KA / CorMedix Inc.

On May 13, 2026 - Jpmorgan Chase & Co filed a 13F-HR/A form disclosing ownership of 115,960 shares of CorMedix Inc. (DE:19KA) valued at $649,376 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 107,768 shares of CorMedix Inc.. This represents a change in shares of 7.60% during the quarter. The current value of the position is $828,882 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 CORMEDIX COMMON 21900C308 115,960 8,192 7.60 762 -39.27 0.0000
2026-02-11 2025-12-31 13F CORMEDIX COMMON 21900C308 107,768 10,540 10.84 1,253 10.88 0.0001
2025-11-26 2025-09-30 13F/A-1 CORMEDIX COMMON 21900C308 97,228 62,085 176.66 1,131 161.57 0.0001
2025-11-07 2025-09-30 13F CORMEDIX COMMON 21900C308 97,228 62,085 1,131 0.0001
2025-08-12 2025-06-30 13F CORMEDIX COMMON 21900C308 35,143 -1,094 -3.02 433 93.72 0.0000
2025-05-12 2025-03-31 13F CORMEDIX COMMON 21900C308 36,237 -236,981 -86.74 223 -89.92 0.0000
2025-02-12 2024-12-31 13F CORMEDIX COMMON 21900C308 273,218 79,110 40.76 2,213 41.14 0.0002
2024-12-26 2024-09-30 13F/A-1 CORMEDIX COMMON 21900C308 194,108 169,397 685.51 1,568 1,379.25 0.0001
2024-11-08 2024-09-30 13F CORMEDIX COMMON 21900C308 194,108 169,397 1,568 0.0001
2024-12-26 2024-06-30 13F/A-1 CORMEDIX COMMON 21900C308 24,711 2,467 11.09 107 12.77 0.0000
2024-08-12 2024-06-30 13F CORMEDIX COMMON 21900C308 24,711 2,467 107 0.0000
2024-12-26 2024-03-31 13F/A-1 CORMEDIX COMMON 21900C308 22,244 -15,481 -41.04 94 -33.33 0.0000
2024-05-10 2024-03-31 13F CORMEDIX COMMON 21900C308 22,244 -15,481 94 0.0000
2024-12-26 2023-12-31 13F/A-1 CORMEDIX COMMON 21900C308 37,725 3,156 9.13 142 11.02 0.0000
2024-02-12 2023-12-31 13F CORMEDIX COMMON 21900C308 37,725 3,156 142 0.0000
2023-11-14 2023-09-30 13F CORMEDIX COMMON 21900C308 34,569 -24,109 -41.09 128 -45.26 0.0000
2023-08-11 2023-06-30 13F CORMEDIX COMMON 21900C308 58,678 58,483 29,991.28 233 23,100.00 0.0000
2023-05-18 2023-03-31 13F/A-1 CORMEDIX COMMON 21900C308 195 0 0.00 1 0.0000
2023-05-11 2023-03-31 13F CORMEDIX COMMON 21900C308 195 0 1 0.0000
2023-02-13 2022-12-31 13F CORMEDIX COMMON 21900C308 195 -21,388 -99.10 0 -100.00 0.0000
2022-11-14 2022-09-30 13F CORMEDIX COMMON 21900C308 21,583 -57,290 -72.64 62 -80.44 0.0000
2022-08-11 2022-06-30 13F CORMEDIX COMMON 21900C308 78,873 38,431 95.03 317 43.44 0.0000
2022-05-11 2022-03-31 13F CORMEDIX COMMON 21900C308 40,442 1,968 5.12 221 26.29 0.0000
2022-02-11 2021-12-31 13F/A-1 CORMEDIX COMMON 21900C308 38,474 11,390 42.05 175 38.89 0.0000
2022-02-10 2021-12-31 13F CORMEDIX COMMON 21900C308 38,474 11,390 175 0.0000
2021-11-12 2021-09-30 13F CORMEDIX COMMON 21900C308 27,084 -23,359 -46.31 126 -63.58 0.0000
2021-08-12 2021-06-30 13F CORMEDIX COMMON 21900C308 50,443 -7,903 -13.55 346 -40.65 0.0000
2021-05-12 2021-03-31 13F CORMEDIX COMMON 21900C308 58,346 -27,373 -31.93 583 -8.33 0.0001
2021-02-19 2020-12-31 13F/A-1 CORMEDIX COMMON 21900C308 85,719 56,897 197.41 636 274.12 0.0001
2021-02-11 2020-12-31 13F CORMEDIX COMMON 21900C308 85,719 56,897 636 93.4379
2020-11-12 2020-09-30 13F/A-1 CORMEDIX COMMON 21900C308 28,822 14,858 106.40 170 93.18 0.0000
2020-11-12 2020-09-30 13F CORMEDIX COMMON 21900C308 28,822 170
2020-08-11 2020-06-30 13F CORMEDIX COMMON 21900C308 13,964 5,799 71.02 88 203.45 0.0000
2020-05-12 2020-03-31 13F CORMEDIX COMMON 21900C308 8,165 -18,711 -69.62 29 -85.13 0.0000
2020-02-11 2019-12-31 13F CORMEDIX COMMON 21900C308 26,876 19,150 247.86 195 297.96 0.0000
2019-11-12 2019-09-30 13F CORMEDIX COMMON 21900C308 7,726 1,253 19.36 49 0.00 0.0000
2019-08-07 2019-06-30 13F CORMEDIX COMMON 21900C308 6,473 6,473 49 0.0000
2016-11-04 2016-09-30 13F CORMEDIX COMMON 21900C100 0 -14,704 -100.00 0 -100.00
2016-08-08 2016-06-30 13F CORMEDIX COMMON 21900C100 14,704 14,704 29 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.